Sector Chart Avalo Therapeutics, Inc.

Stocks

AVTX

US05338F3064

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 21:03:16 08/09/2026 +03			5-day change	1st Jan Change
19.92 ^USD	+3.59%		+5.44%	+10.02%

08-19	Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing	MT
08-06	Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
AVALO THERAPEUTICS, INC.	1.03B	-	-	-	-	-
WUXI APPTEC CO., LTD.	67.82B
ARGENX SE	63.22B
INSMED INCORPORATED	27.58B					-
BIONTECH SE	26.06B					-
WUXI BIOLOGICS (CAYMAN) INC.	25.38B